Vial
Biotechnology ResearchCalifornia, United States51-200 Employees
Vial is a hyper scalable biotech — advancing programs into the clinic powered by dramatically cheaper trials and computationally designed therapeutics.
Strategic Partnerships Vial has recently formed strategic partnerships with industry-leading organizations like Bymason and MLM Medical Labs, indicating potential collaboration opportunities and expanded service offerings through referrals or joint ventures.
New Service Initiatives With the launch of initiatives such as 'First in Human: The Panel Series' and 'The Panel Series,' Vial is demonstrating innovation in engaging with experts and customers, providing a platform to showcase expertise and potentially attract new clients.
Talented Leadership Key hires like Amy Del Medico and Emma C. Moran in leadership positions signify Vial's commitment to strengthening its expertise and capabilities, creating potential networking avenues and avenues for collaboration with their professional networks.
Global Expansion By partnering with Royale International and expanding their network, Vial is indicating a focus on global presence and accessing new markets, presenting sales professionals with opportunities to tap into diverse geographic regions through collaborative efforts.
Financial Stability Vial's healthy funding of $67M and revenue range of $10M - $50M showcases financial stability, indicating potential for long-term partnerships or contracts with clients seeking reliable and financially sound partners for their research and development projects.
Vial uses 8 technology products and services including Microsoft Excel, Font Awesome, Slick, and more. Explore Vial's tech stack below.
Vial Email Formats | Percentage |
First@vial.com | 69% |
FirstLast@vial.com | 22% |
First.Last@vial.com | 6% |
First.L@vial.com | 3% |
Biotechnology ResearchCalifornia, United States51-200 Employees
Vial is a hyper scalable biotech — advancing programs into the clinic powered by dramatically cheaper trials and computationally designed therapeutics.
Vial has raised a total of $67M of funding over 3 rounds. Their latest funding round was raised on Nov 30, 2022 in the amount of $67M.
Vial's revenue is in the range of $10M$50M
Vial has raised a total of $67M of funding over 3 rounds. Their latest funding round was raised on Nov 30, 2022 in the amount of $67M.
Vial's revenue is in the range of $10M$50M